Market Overview

GENTRONIX Receives French Research Tax Credit Accreditation


Gentronix Limited, the genotoxicity innovation and service company, is pleased to announce that it has received French research tax credit approval for years 2012 through 2014.

The French Ministry of Research (Ministère de l'Enseignement Supérieur et de la Recherche) has granted the French R&D tax credit ("Crédit d'Impôt Recherche", CIR) accreditation to Gentronix as of October 2012. This initiative allows eligible research-intensive French companies who are subject to corporate tax in France, the ability to claim tax relief on costs generated in R&D requirements that are outsourced to Gentronix.

John Nicholson, CEO and Chairman of Gentronix commented: “We are extremely pleased to receive this approval from the French Ministry of Research since it will provide Gentronix with greater opportunities to support current and future customers in this important European market.”


About Gentronix

Genotoxins are chemicals that can damage DNA, and may be carcinogens. Gentronix Ltd provides genotoxicity screening products and services for companies who develop new compounds in fields such as pharmaceuticals, agrichemicals, flavours and fragrances, personal care and consumer products.

In addition to conventional genotoxicity testing, Gentronix uses its own patented assays, BlueScreen™HC and GreenScreen®HC, which use human cells that have been genetically modified to give a sensitive and specific response when a chemical damages or interferes with its DNA. For more information, see, or email us at

Gentronix Limited
Dr. Steve Beasley, Commercial Director,
Tel: +44 (0)161 603 7676
Press Information
Barrett Dixon Bell
Dr. Catherine Butcher, or Nicola Aldren,
Tel: +44 (0)161 925 4700
Fax: +44 (0)161 925 4701

View Comments and Join the Discussion!